GelTex Pharmaceuticals (GELX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GelTex Pharmaceuticals (GELX)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: ADEL 7 who wrote (28)	10/15/1997 10:15:00 PM
From: Robert Holmes	of 127

To All: Don't be disuaded by misinformation. RenaGel does not effect cholesterol levels. That is the domain of GelTex's Cholestagel which enters Phase III trials this Qtr. RenaGel is a phosphate binder that has shown little or even no side effects and is scheduled for an NDA filing also this Qtr. For anyone who may be short this stock, a word of warning. Geltex has been in ongoing discussions with potential partners for marketing Cholestagel and has expressed a desire to finalize a partnership prior to its phase III trials (again this qtr). Whether this happens is anyone's guess, but I wouldn't bet against this stock.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next